@article{dad7093b605b4bb6b7aefcc72be3225d,
title = "Phase III study of proton beam irradiation for the treatment of subfoveal choroidal neovascularization in age-related macular degeneration: Treatment techniques and preliminary results",
keywords = "Dose escalation, Macular degeneration, Proton, Radiation morbidity, Subfoveal choroidal neovascularization",
author = "Yonemoto, \{Leslie T.\} and Slater, \{Jerry D.\} and Friedrichsen, \{Eric J.\} and Loredo, \{Lilia N.\} and Jeffrey Ing and Archambeau, \{John O.\} and Sandra Teichman and Moyers, \{Michael F.\} and Blacharski, \{Paul A.\} and Slater, \{James M.\}",
note = "Funding Information: ARMD have the exudative form (choroidal neovascular-ization, CNV, and its sequelae); however, up to 88\% of the legal blindness associated with ARMD results from this form of the disease( 34). Choroidal neovascularization is characterized by proliferation of new lsesselsfr om the choriocapillaris into the subretinal space, from which leak serum, blood, and lipids. This process results in organized scar tissue and a cicatricial disciform lesion, leading to significant and permanent loss of central vision ( 12). The management of CNV is difficult and controversial when it involves the subfovea, i.e., subfoveal CNV. The natural history of subfoveal CNV results in a very poor prognosis E-mail:
[email protected] Acknowledgements-This work was supported from The Hearst Foundation. We thank William for editorial contributions Accepted for publication 19 June I YYh.",
year = "1996",
month = nov,
day = "1",
doi = "10.1016/S0360-3016(96)00339-2",
language = "English",
volume = "36",
pages = "867--871",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
number = "4",
}